Calysta
PrivateLast Round
Series D
Extension
Sep 9, 2021
Total Funding Raised
$156M
Company Overview
Calysta is a biotechnology company that develops and commercializes sustainable, fermentation-based protein ingredients for the aquaculture, livestock, and pet food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Carbon Capture
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calysta Comparables
Compare Calysta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeNova | 85% | |
| Unibio | 84% | |
| String Bio | 80% |
Calysta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 9, 2021 | ||||
| Strategic | Jun 27, 2019 | ||||
| Series D | May 1, 2017 | ||||
| Series C | Feb 2, 2016 | ||||
| Grant | Jan 12, 2016 | ||||
Series B | Jan 22, 2015 |
Key People
Founding team and executive leadership
Calysta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Municipal Employees' Retirement System of Michigan | Series D, Series C |
| Temasek | Series D |
| UK government | Grant |
| Aqua-Spark | Series B, Series C, Series D, Series D Extension |
| Baruch Future Ventures | Series D |
| Bessemer Trust | Series C |
| Walden International | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
R&D labs and pilot plants in the US and UK have been closed.
- Oct 1, 2025
Launched 'microbial protein', a patented fermented feed pellet for fish farms.
Recent news
Latest coverage and updates
- hiresAug 5, 2026
Calysta, Inc. hires Berend Jan Kingma as CEO.
Calysta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Calysta's valuation, stock price, and market status.
Is Calysta a public or private company?
Calysta is a private company.
What is the current stock price of Calysta?
Calysta is a private company with no public stock price. No recent secondary market data is available.
How much is Calysta worth (valuation)?
Valuation information for Calysta is not publicly available.
Can I buy Calysta stock?
Calysta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Calysta's last funding round?
Calysta's most recent funding round was Series D Extension on September 9, 2021.
Who are the main investors in Calysta?
Key investors in Calysta include Municipal Employees' Retirement System of Michigan, Walden International, Riverwood Capital, Pangaea Ventures, BP Ventures.
Will Calysta IPO soon?
No public IPO plans have been announced for Calysta.
How can I track Calysta secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Calysta's secondary market activity and sign up for updates.